Group One Trading’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-13,900
| Closed | -$182K | – | 7623 |
|
|
2025
Q4 | $182K | Buy |
+13,900
| New | +$166K | ﹤0.01% | 4463 |
|
|
2025
Q1 | – | Sell |
-59,900
| Closed | -$536K | – | 7563 |
|
|
2024
Q4 | $536K | Hold |
59,900
| – | – | ﹤0.01% | 3112 |
|
|
2024
Q3 | $659K | Buy |
59,900
+49,600
| +482% | +$551K | ﹤0.01% | 2651 |
|
|
2024
Q2 | $93.7K | Sell |
10,300
-95,700
| -90% | -$934K | ﹤0.01% | 4012 |
|
|
2024
Q1 | $1.49M | Buy |
106,000
+91,000
| +607% | +$1.13M | 0.01% | 1731 |
|
|
2023
Q4 | $115K | Buy |
15,000
+4,900
| +49% | +$27.1K | ﹤0.01% | 4336 |
|
|
2023
Q3 | $75.3K | Buy |
10,100
+9,200
| +1,022% | +$78.5K | ﹤0.01% | 4714 |
|
|
2023
Q2 | $7.5K | Sell |
900
-6,400
| -88% | -$73.8K | ﹤0.01% | 6541 |
|
|
2023
Q1 | $97.1K | Hold |
7,300
| – | – | ﹤0.01% | 4328 |
|
|
2022
Q4 | $109K | Buy |
+7,300
| New | +$75.3K | ﹤0.01% | 4368 |
|
|
2021
Q3 | – | Sell |
-19,000
| Closed | -$241K | – | 8152 |
|
|
2021
Q2 | $241K | Sell |
19,000
-13,617
| -42% | -$177K | ﹤0.01% | 5017 |
|
|
2021
Q1 | $566K | Buy |
32,617
+27,600
| +550% | +$499K | ﹤0.01% | 3874 |
|
|
2020
Q4 | $64K | Buy |
5,017
+4,850
| +2,904% | +$86.4K | ﹤0.01% | 4852 |
|
|
2020
Q3 | $6K | Buy |
+167
| New | +$6.62K | ﹤0.01% | 5565 |
|
Group One Trading's ATXS Position: Q4 2025 in Review
Group One Trading sold out of Astria Therapeutics (ATXS) in Q4 2025, closing a stake of 100 shares — an estimated $1.19K sold.
Group One Trading first reported a position in ATXS in Q3 2020 and held it in 15 quarters. The position peaked at $445K in Q1 2024. 141 funds tracked by Wall St. Rank hold ATXS as of Q4 2025.
- Group One Trading reported no remaining Astria Therapeutics position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 100 Astria Therapeutics shares in Q4 2025, an estimated $1.19K.
- Group One Trading first reported a position in Astria Therapeutics in Q3 2020 and held it in 15 quarters.
- Group One Trading's Astria Therapeutics position peaked at $445K in Q1 2024.
- 141 funds tracked by Wall St. Rank held Astria Therapeutics as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.